NDC 68151-3118 Clopidogrel Bisulfate
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 68151 - Carilion Materials Management
- 68151-3118 - Clopidogrel Bisulfate
Product Characteristics
Product Packages
NDC Code 68151-3118-9
Package Description: 1 TABLET, FILM COATED in 1 PACKAGE
Product Details
What is NDC 68151-3118?
What are the uses for Clopidogrel Bisulfate?
Which are Clopidogrel Bisulfate UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLOPIDOGREL BISULFATE (UNII: 08I79HTP27)
- CLOPIDOGREL (UNII: A74586SNO7) (Active Moiety)
Which are Clopidogrel Bisulfate Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for Clopidogrel Bisulfate?
- RxCUI: 309362 - clopidogrel 75 MG Oral Tablet
- RxCUI: 309362 - clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".